0
0
12/13/22 at 12:55pm
Organization
News-Medical.Net
40 words
0
Comments
Researchers assessed the impact of bebtelovimab (BEB) monoclonal antibody in the treatment of high-risk SARS-CoV-2 Omicron variant-infected patients.
You are the first to view
https://www.news-medical.net/news/20221213/Study-finds-bebtelovimab-therapy-lacks-efficacy-in-patients-infected-with-SARS-CoV-2-Omicron-subvariants.aspx
Create an account
or login to join the discussion